Low-cost photoionization sensors as detectors in GC × GC systems designed for ambient VOC measurements.

Conventional volatile organic compound (VOC) monitoring based on thermal desorption - gas chromatography-mass spectrometry (TD-GC-MS) or gas chromatography-flame ionization detector (TD-GC-FID) is relatively cumbersome and expensive. In this study commercial off the shelf low-cost and low-power photo-ionization detector (PID) sensors are used as simple detectors in VOC analysis systems based on GC, including a miniaturised GC × GC device with portable, low-cost, and low-energy-consumption features. PID sensors produce a voltage signal positively proportional to VOC concentration, which when incorporated into a TD-GC system gave limit of detection of 0.02 ppbV for isoprene. To test PID performance in real-world applications, PID sensors were deployed as (i) a second alternative detector in a GC-Quadruple Time Of Flight Mass spectrometry (GC-Q-TOF-MS), and (ii) the main detector in a compact two-dimensional gas chromatograph (GC × GC). PID sensors with 10.6 eV and 11.7 eV lamps were used to measure eight toxic chemicals including organic sulfide and organic phosphonates via GC; two species were ionized by a 10.6 eV lamp and four species by the 11.7 eV lamp. Commercially available low-cost PIDs designed for standalone could be straightforwardly and effectively re-used as detectors in compact GC × GC systems, in this work showing excellent VOC sensitivity, fast response and low operational demands compared to comparable field instruments based on GC-FID or MS.

Inhibition of mTOR enhances radiosensitivity of lung cancer cells and protects normal lung cells against radiation.

Radiotherapy has been used for a long time as a standard therapy for cancer; however, there have been no recent research breakthroughs. Radioresistance and various side-effects lead to the unexpected outcomes of radiation therapy. Specific and accurate targeting as well as reduction of radioresistance have been major challenges for irradiation therapy. Recent studies have shown that rapamycin shows promise for inhibiting tumorigenesis by suppressing mammalian target of rapamycin (mTOR). We found that the combination of rapamycin with irradiation significantly diminished cell viability and colony formation, and increased cell apoptosis, as compared with irradiation alone in lung cancer cell line A549, suggesting that rapamycin can enhance the effectiveness of radiation therapy by sensitizing cancer cells to irradiation. Importantly, we observed that the adverse effects of irradiation on a healthy lung cell line (WI-38) were also offset. No enhanced protein expression of mTOR signaling was observed in WI-38 cells, which is normally elevated in lung cancer cells. Moreover, DNA damage was significantly less with the combination therapy than with irradiation therapy alone. Our data suggest that the incorporation of rapamycin during radiation therapy could be a potent way to improve the sensitivity and effectiveness of radiation therapy as well as to protect normal cells from being damaged by irradiation.

[In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].

OBJECTIVE: To investigate in vivo distribution and pharmacokinetics of ginsenoside Rb1 (Rb1), ginsenoside Rg1 (Rg1 ) and sanchinoside R1 (R1) after intratympanic administration (IT) or intravenous administration (IV) of Panax notoginseng saponions (PNS) solution, and provide a novel route for delivering traditional Chinese medicine (TCM) to the brain. METHOD: The guinea pigs were employed as experimental animal. Perilymph (PL), cerebrospinal fluid (CSF), brain tissue and plasma were collected periodically after IT and IV of PNS solution. The concentrations of Rb1, Rg1 and R1 were measured by high performance liquid chromatography (HPLC), and statistic program DAS was applied to the calculation of pharmacokinetic parameters. The self-defined weighting coefficients based on area under curve (AUC) of each component were created to obtain the holistic pharmacokinetic profiles of PNS. The integrated pharmacokinetic parameters were then calculated from non-compartmental model analysis. RESULT: Rb1, Rg1 and R1 diffused through the round window membrane into PL of the inner ear, and then transported to the brain after IT of PNS solution. However, the pharmacokinetic parameters showed significant differences between the three components. Based on the self-defined AUC weighting coefficients integration approach, the holistic pharmacokinetic profiles of PNS were obtained, from which the integrated pharmacokinetic parameters were calculated. The C(max) in CSF and brain tissues following IT were respectively 1.5 and 0.4-fold higher than those following IV. After IT, the AUC in CSF and brain tissues increased by 0.5 and 1.2 times compared with IV. Furthermore, the C(max) and AUC in plasma following IT were respectively 45.9% and 33.1% lower than those following IV. CONCLUSION: This novel intra-cochlear administration might serve as a potential and promising alternative to TCM delivery with enhanced brain-targeted efficiency.